Rituximab in refractory chronic inflammatory demyelinating polyradiculoneuropathy: report of four cases
Author:
Publisher
Springer Science and Business Media LLC
Subject
Neurology (clinical),Neurology
Link
http://link.springer.com/content/pdf/10.1007/s00415-017-8462-7.pdf
Reference16 articles.
1. Lunn MPT, Manji H, Choudhary PP, Hughes RAC, Thomas PK (1999) Chronic inflammatory demyelinating polyradiculoneuropathy: a prevalence study in south east England. J Neurol Neurosurg Psychiatry 66:677–680
2. Mathey EK, Park SB, Hughes RA, Pollard JD, Armati PJ, Barnett MH, Taylor BV, Dyck PJ, Kiernan MC, Lin CS (2015) Chronic inflammatory demyelinating polyradiculoneuropathy: from pathology to phenotype. J Neurol Neurosurg Psychiatry 86(9):973–985
3. Koller H, Kieseier B, Jander S, Hartung H (2005) Chronic inflammatory demyelinating polyneuropathy. N Engl J Med 352:1343–1356
4. Mahdi-Rogers M, van Doorn PA, Hughes RA (2013) Immunomodulatory treatment other than corticosteroids, immunoglobulin and plasma exchange for chronic inflammatory demyelinating polyradiculoneuropathy. Cochrane Database Syst Rev (6):CD003280
5. European Federation of Neurological Societies/Peripheral Nerve Society (2010) Guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy: report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society–First Revision. Joint Task Force of the EFNS and the PNS. J Peripher Nerv Syst 15(1):1–9
Cited by 25 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Long‐term and low‐dose rituximab treatment for chronic inflammatory demyelinating polyneuropathy;Journal of the Peripheral Nervous System;2024-08-17
2. Prospective open-label trial with rituximab in patients with chronic inflammatory demyelinating polyradiculoneuropathy not responding to conventional immune therapies;Journal of Neurology, Neurosurgery & Psychiatry;2024-05-10
3. Insights into refractory chronic inflammatory demyelinating polyneuropathy: a comprehensive real-world study;Frontiers in Neurology;2024-01-31
4. Role of regulatory T cells in pathogenesis and therapeutics of chronic inflammatory demyelinating polyradiculoneuropathy;Regulatory T Cells and Autoimmune Diseases;2024
5. Effectiveness and safety of rituximab in autoimmune nodopathy: a single-center cohort study;Journal of Neurology;2023-05-17
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3